Nutex Health Q1 2025: Assets $551.1M, Liabilities $552.8M
Ticker: NUTX · Form: 10-Q · Filed: May 13, 2025 · CIK: 1479681
| Field | Detail |
|---|---|
| Company | Nutex Health, INC. (NUTX) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financials, 10-Q, balance-sheet
TL;DR
Nutex Health Q1 2025: Assets $551.1M, Liabilities $552.8M. Watch for debt.
AI Summary
Nutex Health, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $551.1 million and total liabilities of $552.8 million for the first quarter of 2025. The filing also references a merger agreement dated April 1, 2022, involving Clinigence Holdings, Inc.
Why It Matters
This filing provides a snapshot of Nutex Health's financial position at the end of Q1 2025, indicating a slight net liability position which could impact its financial flexibility.
Risk Assessment
Risk Level: medium — The company's liabilities slightly exceed its assets as of March 31, 2025, which could indicate financial strain.
Key Numbers
- $551.1M — Total Assets (As of March 31, 2025)
- $552.8M — Total Liabilities (As of March 31, 2025)
Key Players & Entities
- Nutex Health, Inc. (company) — Filer
- March 31, 2025 (date) — Reporting period end date
- $551.1 million (dollar_amount) — Total assets for Q1 2025
- $552.8 million (dollar_amount) — Total liabilities for Q1 2025
- Clinigence Holdings, Inc. (company) — Mentioned in relation to a merger agreement
- April 1, 2022 (date) — Date of merger agreement
FAQ
What is Nutex Health's net income or loss for the first quarter of 2025?
The provided snippet does not contain specific net income or loss figures for the first quarter of 2025.
What were the company's revenues for the first quarter of 2025?
The filing snippet does not explicitly state the revenue figures for the first quarter of 2025.
What is the nature of the merger agreement dated April 1, 2022, involving Clinigence Holdings, Inc.?
The filing snippet mentions a merger agreement dated April 1, 2022, related to Clinigence Holdings, Inc., but does not detail the terms or outcome of the agreement.
Are there any significant changes in the company's financial structure compared to the previous quarter or year?
This snippet focuses on the Q1 2025 period and does not provide comparative data to assess changes from prior periods.
What is the company's cash position as of March 31, 2025?
The provided data does not include specific figures for the company's cash or cash equivalents as of March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Nutex Health, Inc. (NUTX).